Skip to main content

4 Result(s)

within B. Mark Keegan Remove this filter

and

  1. No Access

    Article

    Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy

    Shemonti Hasan, Onilia Zorio, B. Mark Keegan, Brian G. Weinshenker… in Journal of Neurology (2023)

  2. No Access

    Article

    Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease

    To determine the diagnostic utility of serial cerebrospinal fluid (CSF) examinations for hematological malignancy causing neurological disease. All CSF cytology reports at Mayo Clinic Rochester from 2005 to 20...

    Eugene L. Scharf, Curtis A. Hanson, Matthew T. Howard… in Journal of Neuro-Oncology (2016)

  3. No Access

    Article

    Secondary intramedullary spinal cord non-Hodgkin’s lymphoma

    Intramedullary spinal cord metastases of solid neoplasms are associated with poor long-term survival. As the characteristics of secondary intramedullary spinal cord non-Hodgkin’s lymphoma (NHL) are not well un...

    Eoin P. Flanagan, Brian Patrick O’Neill, Thomas M. Habermann… in Journal of Neuro-Oncology (2012)

  4. No Access

    Article

    Atypical Acute Hemorrhagic Leukoencephalitis (Hurst’s disease) Presenting with Focal Hemorrhagic Brainstem Lesion

    Acute hemorrhagic leukoencephalitis (AHL; Hurst’s disease) is a rare, severe, inflammatory CNS disease that is typically diffuse, multifocal and associated with petechial hemorrhage. The objective of this stud...

    Nuhad E. Abou Zeid, Joseph D. Burns, Eelco F. M. Wijdicks… in Neurocritical Care (2010)